Table of Content

1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.3 Market Restraints
4.4 Porter’s Five Forces Analysis
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Consumers
4.4.3 Threat of New Entrants
4.4.4 Threat of Substitute Products and Services
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 Insulin Pumps
5.1.1 Insulin Pump Devices
5.1.2 Insulin Pump Reservoirs
5.1.3 Insulin Infusion sets
5.2 Insulin Pens
5.2.1 Cartridges in reusable pens
5.2.2 Disposable insulin pens
5.3 Insulin Syringes
5.4 Insulin Jet Injectors


6 MARKET INDICATORS
6.1 Type-1 Diabetes population (2017 - 2028)
6.2 Type-2 Diabetes population (2017 - 2028)


7 COMPETITIVE LANDSCAPE
7.1 COMPANY PROFILES
7.1.1 Novo Nordisk
7.1.2 Sanofi
7.1.3 Eli Lilly
7.1.4 Biocon
7.1.5 Julphar
7.1.6 Medtronic
7.1.7 Ypsomed
7.1.8 Becton Dickinson
7.1.9 Insulet Corporation
7.2 COMPANY SHARE ANALYSIS
7.2.1 Insulet Corporation
7.2.2 Novo Nordisk
7.2.3 Medtronic


8 MARKET OPPORTUNITIES AND FUTURE TRENDS